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h i g h l i g h t s
• We have investigated how CaSR activation enhances sympathetic axon growth.
• CaSR activation promotes phosphorylation of ERK1 and ERK2.
• Inhibition of ERK1/ERK2 phosphorylation blocks CaSR-promoted axon growth.
• CaSR-promoted axon growth requires a discrete region of the cytoplasmic domain.
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a b s t r a c t
The extracellular calcium-sensing receptor (CaSR) is a G-protein coupled receptor that monitors the
systemic extracellular free ionized calcium level ([Ca2+]o) in organs involved in systemic [Ca2+]o homeo-
stasis. CaSR is widely expressed in the nervous system and its activation promotes axon and dendrite
growth during development, but the mechanism by which it does this is not known. Here we show that
enhanced axon growth and branching from cultured embryonic sympathetic neurons by activation of
the endogenous CaSR depends on the presence of nerve growth factor (NGF). Our observation that acti-
vation of overexpressed CaSR promotes axon growth in NGF-free medium has enabled us to investigate
CaSR downstream signaling contributing to axon growth in the absence of NGF signaling. We show that
activation of overexpressed CaSR leads to activation of ERK1 and ERK2, and pharmacological inhibition of
CaSR-dependent ERK1/ERK2 activation prevents CaSR-dependent axon growth. Analysis of axon growth
from cultured neurons expressing deletionmutants of the CaSR cytoplasmic tail revealed that the region
between alanine 877 and glycine 907 is required for promoting axon growth that is distinct from the
high-afﬁnity ﬁlamin-A binding site that has previously been implicated in ERK1/ERK2 activation.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).
1. Introduction
The CaSR plays a crucial role in monitoring and maintaining
[Ca2+]o within very narrow physiological limits and is conspicu-
ously expressed in the tissues and organs involved in systemic
calcium homeostasis [1]. The CaSR is also widely expressed in the
peripheral and central nervous system, where it has been impli-
cated in a diversity of functions [2]. These include regulating axon
and dendrite growth [3], the migration and/or maintenance of
hypothalamic GnRH neurons [4] and the regulation of neuronal
excitability and synaptic transmission [5,6].
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The molecular mechanisms by which CaSR exerts its effects on
neurons are poorly understood. The CaSR is a member of the C
family of G-protein coupled receptors that associates with three
mainheterotrimericGprotein complexes,Gq/11, Gi/o andG12/13, and
therebymodulates the activity of awide variety of downstreamsig-
naling networks, including PLC-mediated Ca2+ mobilization, cAMP,
Rho kinase and the MAP kinases ERK1/2, p38 and JNK [7]. The
aim of this study was to ascertain how CaSR activation inﬂuences
axon growth and branching using the well-characterized, exper-
imentally tractable sympathetic neurons of the mouse superior
cervical ganglion (SCG) [8]. Previous work has shown that expres-
sion of the CaSR peaks in these neurons in the immediate perinatal
period and that activating the CaSR during this stage of devel-
opment enhances NGF-promoted axon growth, and that this is
important for the establishment of the appropriate level of sym-
pathetic innervation in vivo [3]. Our demonstration that activation
of overexpressedCaSR enhances axongrowth in the absence ofNGF
has enabled us to investigate how the CaSR inﬂuences axon growth
http://dx.doi.org/10.1016/j.neulet.2015.07.019
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without the complication of concomitant NGF signaling. We show
that CaSR-promoted ERK activation contributes to CaSR-promoted
axon growth and identify the region of the CaSR C-terminal domain
required for axon growth.
2. Materials and methods
2.1. Neuron cultures
Dissociated cultures of SCG neurons from CD-1 mice were
grown on poly-ornithine/laminin coated 35mm tissue culture
dishes (Greiner) in Hams F14 medium [9] with 0.25% Albumax I
(Invitrogen). Survival was estimated as described [9]. The neurite
arbors of non-transfected neurons were labelled with calcein-AM
(1:1000, Invitrogen). Neurons transfected with plasmids encoding
full-length CaSR or CaSR mutants were co-transfected with a YFP
plasmid. Fast-Sholl analysis was carried out on imaged neurons
[10].
2.2. Plasmids
The pFLCaSR plasmid was generated by cloning the open read-
ing frame of human CaSR into pcDNA3.1. The pG907stopCaSR and
pA877stopCaSR plasmids were generated by site directed muta-
genesis. Transfection was carried out using the Neon Transfection
system (Invitrogen).
2.3. Immunocytochemistry
Cultures were ﬁxed in ice-cold methanol for 10min, washed in
PBS, blocked and permeabilized with 5% BSA with 0.02% Triton-
X100 in PBS. The cells were incubated with primary antibody in 1%
BSA at 4 ◦C for 18h. The primary antibodies were: anti-III tubu-
lin (Promega, 1:1000), anti-CaSR to the CaSR N-terminal sequence
(Imgenex, 1:1000), anti-phospho ERK1/2 and anti-total ERK1/2
(Cell Signaling Technology, 1:100). After washing, the cells were
incubated with appropriate secondary antibodies conjugated to
either Alexa-488 or Alexa-546 (Invitrogen), 1:600 for 90min. Stain-
ing intensitywas quantiﬁed using pixel intensity using the Volocity
software (PerkinElmer).
3. Results
3.1. CaSR-promoted neurite growth is NGF-dependent
Previous work has shown that activating the CaSR in cul-
tured SCG neurons with elevated levels of [Ca2+]o enhances
NGF-promoted axon growth in the immediate perinatal period [3].
To ascertainwhether or not CaSR activation is able to enhance neu-
rite growth independently of NGF, we compared neurite growth
from E18 SCG neurons cultured with and without NGF in media
containing2.3mM(maximally-activating) and0.7mM(minimally-
activating) levels of [Ca2+]o [3]. Because E18 SCG neurons are
dependentonNGF for survival,weaddedabroad-spectrumcaspase
inhibitor (Boc-D-FMK) to the medium to prevent apoptosis.
In accordance with published observations [3], the neurite
arbors of NGF-supplemented neurons grown in medium contain-
ing 2.3mM [Ca2+]o were much larger and more branched than
those of neurons grown with 0.7mM [Ca2+]o. There were highly
signiﬁcant differences in neurite length (Fig. 1A) and branch point
number (Fig. 1B), and the Sholl proﬁles displayed clear differences
in NGF-supplemented cultures (Fig. 1C). In contrast, the size and
complexity of the neurite arbors of neurons grown without NGF
were not signiﬁcantly different in media containing 0.7mM and
2.3mM [Ca2+]o (Figs. 1A–C). These ﬁndings suggest that activation
of the endogenous CaSR is insufﬁcient to enhance the low level of
neurite growth that occurs in the absence of NGF, but enhances the
magnitude of NGF-promoted neurite growth.
3.2. Over-expression of CaSR promotes neurite growth in the
absence of NGF
The requirement for NGF in CaSR-promoted neurite growth
complicates investigation of the signaling pathways downstream
of CaSR that mediate this effect. Because enhancement of neurite
growth by CaSR activation is only observed in SCG neurons at the
developmental peak of CaSR expression [3], we tested whether
overexpression of CaSR would enhance neurite growth in the
absenceofNGF. Robust high-level CaSRexpressionwas achievedby
transfectingneuronswith apcDNA3.1 vector containing full-length
CaSR (pFLCaSR). Quantiﬁcation of CaSR immunoﬂuorescence con-
ﬁrmed increased CaSR expression in neurons transfected with
pFLCaSR (Fig. 2A).
In the absence of NGF, the neurite arbors of E18 SCG neurons
transfected with pFLCaSR were signiﬁcantly larger than those of
control transfected neurons in medium containing 2.3mM [Ca2+]o
(Fig. 2B, and C). There was no signiﬁcant difference in neurite
arbor size between pFLCaSR transfected and control transfected
neurons in medium containing 0.7mM [Ca2+]o. All cultures were
supplemented with Boc-D-FMK to prevent neuronal death in the
absence of NGF. These ﬁndings suggest that overexpression of CaSR
enhances neurite growth in NGF-free medium containing activat-
ing levels of [Ca2+]o.
Given the above results, we explored the possibility that up-
regulation of CaSR expression contributes to enhanced neurite
growth from non-transfected neurons grown with NGF and acti-
vating levels of [Ca2+]o. We cultured E18 SCG neurons with and
without NGF in media containing either 0.7 or 2.3mM [Ca2+]o and
estimated the relative levels of CaSR immunoﬂuorescence after
24h. All cultures received Boc-D-FMK to prevent apoptosis. There
was no signiﬁcant difference in CaSR immunoﬂuorescence in neu-
rons cultured with either 0.7 or 2.3mM [Ca2+]o in the absence of
NGF (Fig. 2D). However, in the presence of NGF, the level of CaSR
immunoﬂuorescencewas over two-fold higher in neurons cultured
in medium containing 2.3mM [Ca2+]o than in neurons cultured
in medium containing 0.7mM [Ca2+]o (Fig. 2D). Images of CaSR-
labelled neurons cultured with NGF in medium containing either
0.7mM or 2.3mM [Ca2+]o are illustrated in Fig. 2E. This suggests
that CaSR expression is upregulated inmediumcontainingNGF and
activating levels of [Ca2+]o and that this in turn contributes to the
enhancedneurite growthobserved from late fetal neurons cultured
under these conditions.
3.3. ERK1/ERK2 activation by CaSR over-expression contributes
to neurite growth
To elucidate themolecularmechanismunderlying the enhance-
ment of neurite growth from SCG neurons by activated CaSR, we
explored a common link in intracellular signaling between CaSR
signaling and neurite growth. ERK1 and ERK2 are activated by the
CaSR in parathyroid cells, ﬁbroblasts and kidney cell lines [11–15]
and NGF-promoted ERK1/ERK2 activation in PC12 cells and SCG
neurons contributes to the neurite growth response [16–20].
To investigate whether ERK1/ERK2 signaling contributes to
CaSR-promoted neurite growth from E18 SCG neurons, we used
immunoﬂuorescence to estimate the relative levels of phospho-
ERK1/ERK2 in neurons. Phospho-ERK1/ERK2 immunoﬂuorescence
was clearly elevated in NGF-supplemented neurons grown in
2.3mM [Ca2+]o medium compared with NGF-supplemented neu-
rons grown in 0.7mM [Ca2+]o medium and neurons grown in
NGF-free medium containing either 0.7mM or 2.3mM [Ca2+]o
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Fig. 1. CaSR-promoted neurite growth is NGF-dependent.
Neurite length (A), branch point number (B) and Sholl proﬁles (C) of E18 SCG neurite arbors after 24h with and without 10ng/ml NGF in media containing either 0.7mM or
2.3mM [Ca2+]o. All cultures received 50M Boc-D-FMK. Mean± sem of data from 231 to 263 neurons per condition. ***P<0.001, two-tailed, unpaired t-test.
(Fig. 3A). Therewere no differences in total ERK1/ERK2 immunoﬂu-
orescence in neurons grown under these different conditions (not
shown). This suggests that ERK1/ERK2 signaling is elevated in neu-
rons grown with NGF and activating levels of [Ca2+]o.
We subsequently examined whether CaSR overexpression can
activate ERK1/ERK2 in E18 SCG neurons grown in NGF-free
medium. The level of phospho-ERK1/ ERK2 immunoﬂuorescence
was clearly elevated in neurons overexpressing CaSR compared
with control transfected neurons (Fig. 3B). Phospho-ERK1/ERK2
immunoﬂuorescence in neurons transfected with pFLCaSR after
24h in medium containing 2.3mM [Ca2+]o without NGF revealed
a signiﬁcant elevation compared with control-transfected neurons
(Fig. 3C), whereas immunoﬂuorescence for total ERK1/ERK1 was
not signiﬁcantly different (Fig. 3D).
To test whether ERK1/ERK2 activation contributes to the
enhanced neurite growth brought about by CaSR over-expression,
we examined whether U0126, a selective MEK1/MEK2 inhibitor
that interferes with activation of ERK1/ERK2 by MEK1/MEK2
[21], could prevent the increase in CaSR-promoted neurite
growth. In these experiments, we plated pFLCaSR-transfected and
control-transfected SCG neurons in NGF-free medium containing
Boc-D-FMK and either U0126 or its inactive analog U0124. Quan-
tifying neurite arbor size and complexity 24h later revealed that
U0126, but not U0124, completely prevented enhanced neurite
growth accompanying CaSR overexpression (Fig. 3E and F). Nei-
ther U0126 nor U0124 affected neuronal survival in these cultures
(not shown). This suggests that MEK/ERK signaling contributes to
CaSR-promoted neurite growth.
3.4. A discrete region of the CaSR cytoplasmic tail is required for
enhanced neurite growth
Because many of the signaling functions of the CaSR are depen-
dent on the C-terminal cytoplasmic domain [22,23], we transfected
E18 SCG neurons with plasmids that express C-terminal trun-
cation mutants and quantiﬁed neurite growth after 24h culture
in NGF-free medium containing 2.3mM [Ca2+]o. The G907stop
CaSR mutant lacks the high-afﬁnity binding site for ﬁlamin-A [15]
and a PKC phosphorylation site. The A877stop CaSR mutant lacks
additional PKC phosphorylation sites, a PKA phosphorylation site,
arginine rich motifs and a low-afﬁnity binding site for ﬁlamin-A
[15,23].
Sholl analysis showed that the neurite arbors of E18 SCG
neurons transfected with the pG907stopCaSR expression plas-
mid were of similar size to those of neurons transfected
with pFLCaSR, whereas the neurite arbors of control-transfected
neurons were very much smaller (Fig. 4A). There were no
signiﬁcant differences in neurite length and branch point num-
ber between pG907stopCaSR-transfected and pFLCaSR-transfected
neurons (P=0.9, ANOVA, data not shown), whereas control-
transfected neurons were signiﬁcantly shorter and less branched
(P<0.0001, Kruskal–Wallis test, data not shown). In contrast, the
neurite arbors of pA877stopCaSR-transfected neurons were no
larger than those of control-transfected neurons (Fig. 4B), and there
were no signiﬁcant differences in neurite length and branch point
number between these groups (P=0.8, ANOVA). This suggests that
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Fig. 2. Over-expression of CaSR promotes neurite growth in the absence of NGF.
(A) Quantiﬁcation of CaSR immunoﬂuorescence in E18 SCG neurons 24h after transfection with either pFLCaSR or pcDNA3.1, mean± sem (****P<0.0001, unpaired t-test
with Welch’s correction, n=24 cells per condition). Total length (B) and branch point number (C) of the neurite arbors of E18 SCG neurons transfected with either pcDNA3.1
or pFLCaSR and cultured without NGF for 24h in medium containing 2.3mM [Ca2+]o. All cultures received 50M Boc-D-FMK. Mean± sem of data from 592 to 620 neurons
per condition. ***P<0.001, two-tailed, unpaired t-test. (D) Quantiﬁcation of CaSR immunoﬂuorescence in non-transfected SCG neurons cultured for 24h with and without
10ng/ml NGF in media containing either 0.7mM or 2.3mM [Ca2+]o. ***P<0.001, ANOVA with Bonferroni’s post-hoc test (n=24 per condition). (E) Representative images of
SCG neurons double labelled for CaSR and III-tubulin after 24h in media containing 10ng/ml NGF with either 0.7mM or 2.3mM [Ca2+]o. Scale bar =20m.
a region between residues alanine 877 and glycine 907 is required
for CaSR-enhanced neurite growth.
4. Discussion
Previousworkhas shownthat theCaSRregulatesneuritegrowth
and tissue innervation in the developing sympathetic nervous sys-
tem [3]. In the current study, we have investigated how CaSR
activation enhances neurite growth from SCG neurons. Our obser-
vation that activating levels of [Ca2+]o enhance axon growth and
branching from cultured SCG neurons overexpressing the CaSR in
the absence of NGF has enabled us to investigate how CaSR signal-
ing affects neurite growth without the confounding effect of NGF
signaling.
We focused on a common link in intracellular signaling between
CaSR signaling and the regulation of neurite growth. Several stud-
ies have shown that CaSR activation in a variety of cell types,
including parathyroid cells, ﬁbroblasts and kidney cell lines, leads
to phosphorylation and activation of ERK1 and ERK2 [11–15] and
ERK1/ERK2 activation in neurons and neural cell lines by NGF con-
tributes to the neurite growth response [16–20].
Two observations suggest that ERK1/ERK2 activation is a key
step by which CaSR activation enhances neurite growth. First,
activating but not minimally-activating levels of [Ca2+]o promote
phosphorylation of ERK1 and ERK2 in SCG neurons overexpressing
the CaSR. Second, pharmacological inhibition of the kinases that lie
upstream of ERK1 and ERK2, MEK1 and MEK2, prevents activating
levels of [Ca2+]o enhancing axon growth. While these observations
do not rule out the possibility that other signaling pathways acti-
vatedby theCaSRmaycontribute to its inﬂuenceonneurite growth,
theseﬁndings suggest thatERK1/ERK2activation is anecessary step
in the neurite growth-promoting effects of the CaSR.
Todetermine the region of theCaSR required for enhancingneu-
rite growth, we overexpressed CaSR deletion mutants to ascertain
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Fig. 3. ERK1/ERK2 activation by CaSR contributes to neurite growth.
(A) Images of non-transfected E18 SCG neurons double labelled for phospho-ERK1/ ERK2 andIII-tubulin after 24hwith andwithout 10ng/ml NGF inmedia containing either
0.7mM or 2.3mM [Ca2+]o. (B) Images of double labelled E18 SCG neurons after 24h incubation in NGF-free medium containing 2.3mM [Ca2+]o after transfection with either
pcDNA3.1 or pFLCaSR. Scale bar =20m. (C and D) Quantiﬁcation of phospho-ERK1/ERK2 immunoﬂuorescence (C) and total ERK1/ERK2 immunoﬂuorescence (D) in E18 SCG
neurons cultured for 24h in NGF-free medium containing 2.3mM [Ca2+]o plus 50M Boc-D-FMK transfected with either pFLCaSR or an pcDNA3.1. Mean± sem of data from
40 neurons per condition. ***P<0.001, unpaired t-test with Welch’s correction. Total length (E) and branch point number (F) of E18 SCG neurons cultured without NGF for
24h in media containing 2.3mM [Ca2+]o plus 50M Boc-D-FMK and either 10M U0124 or 10M U0126 after transfection with either pFLCaSR or pcDNA3.1. Mean± sem
of data from 214 to 249 neurons per condition. ****P<0.0001, ANOVA with Bonferroni’s post-hoc test.
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Fig. 4. A discrete region of the CaSR cytoplasmic tail is required for enhanced neurite growth.
(A) Sholl plots of E18 SCG neurite arbors after 24h in NGF-free medium containing 2.3mM [Ca2+]o plus 50M Boc-D-FMK after transfection with either pcDNA3.1, pFLCaSR
or pG907stopCaSR (data from 223 to 259 neurons per condition). (B) Neurons transfected with either pcDNA3.1, pFLCaSR or pA877stopCaSR (data from 182 to 210 neurons
per condition).
the minimum length of the CaSR intracellular domain required for
enhancing neurite growth in the presence of activating levels of
[Ca2+]o. Because activation of ERK1/ERK2 by the CaSR depends on
direct interactionof theCaSRcarboxyl terminuswith the cytoskele-
tal scaffold protein ﬁlamin A [13,15,24], we used deletion mutants
that lack one or both binding sites for ﬁlamin A. Overexpression
of the G907stop mutant, which lacks the high-afﬁnity ﬁlamin-A
binding site [15], was just as effective as overexpressed full-length
CaSR in promoting neurite growth inmediumcontaining activating
levels of [Ca2+]o, indicating that the high-afﬁnity ﬁlamin A binding
site is not required for CaSR-promoted neurite growth. It is possible
that this partially truncated mutant may enhance neurite growth
by a mechanism that differs from that of full-length CaSR. A recent
study inHEK-293 cells has also shown that the high-afﬁnity ﬁlamin
A binding site is also dispensable for ERK1/ERK2 activation by the
CaSR [15]. Overexpression of the A877stop CaSR mutant failed to
enhance neurite growth with activating levels of [Ca2+]o, suggest-
ing that the region between residues alanine 877 and glycine 907
is required for CaSR-enhanced neurite growth. This region not only
possesses a low-afﬁnity ﬁlamin A binding site [15], but also con-
tains PKC phosphorylation sites [25–28] and residues necessary for
PI-PLC activation [29]. These ﬁndings are consistent with the pos-
sibility that the low-afﬁnity ﬁlamin A binding site is important,
but raise the possibility that other sites within this short stretch
of the C-terminal domain contribute to CaSR-promoted neurite
growth. Furthermolecular dissection of this regionwill be required
to address this possibility.
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